Reducing the frequency of eye screening in patients with diabetes from annually to every other year would delay detection of sight-threatening diabetic retinopathy (STDR) and proliferative diabetic ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window While artificial ...

Please provide your email address to receive an email when new articles are posted on . KOLOA, Hawaii — Stratifying patients based on risk factors could help address the demand for more diabetic ...

Despite guidelines recommending annual screenings, nearly half of patients with diabetes miss critical eye exams, explains Jose A. Martinez, MD, president and retina specialist at Austin Retina ...

Artificial intelligence (AI)-based retinal image analysis detects sight-threatening diabetic retinopathy as accurately as human graders, but is not yet licensed in the National Health Service's ...

Quest Diagnostics is partnering with Intelligent Retinal Imaging Systems to expand its offering of diabetic retinal imaging services. Quest said April 4 that the IRIS platform for diabetic retinopathy ...

The preparation of evidence-based guidelines is highlighted by the WHO as an important component in the concerted effort to eliminate avoidable blindness. [149] This review has highlighted ...

Please provide your email address to receive an email when new articles are posted on . The use of artificial intelligence in screening for diabetic retinopathy led to accurate referrals in Rwanda ...

India has launched its first AI-driven diabetic retinopathy programme to address blindness in diabetic patients. It is an emerging preventable cause of blindness in India, with major advancements in ...

Forbes contributors publish independent expert analyses and insights. Gil Press writes about technology, entrepreneurs and innovation. There are 35 million diabetics in the U.S. and over 420 million ...

SECAUCUS, N.J., April 4, 2022 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a collaboration with IRIS (Intelligent ...